SCHEMBL13877910

SCHEMBL13877910

COC(=O)N1[C@@]2(C)C=C[C@]1(C)C[C@@](O)(c1ccc(NC(=O)c3nc(C)c[nH]3)c(C3=CCC(C)(C)CC3)c1)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13877981 0.90 — —
SCHEMBL3704863 0.90 — —
SCHEMBL13877909 0.86 — —
SCHEMBL14383682 0.85 — —
SCHEMBL14374730 0.85 — —
SCHEMBL13877912 0.84 — —
SCHEMBL14374725 0.82 — —
SCHEMBL14374721 0.82 — —
SCHEMBL19264778 0.82 — —
SCHEMBL13877911 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8497376-B2 4-Cyano-1H-imidazole-2-carboxylic acid [2-cyclohex-1-enyl-4-(2,6-dioxo-piperidin-4-yl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent JANSSEN PHARMACEUTICA N.V. (BE) 2013-07-30 — — US disclosed
US-20090105296-A1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-23 — — US disclosed
Send feedback